The largest global AIDS corporation.

AHF, the largest global AIDS corporation, accuses the business of lying about its cooperation with the HIV/AIDS community and refutes the following claim created by BMS: ‘For last 20 years, Bristol-Myers Squibb spent some time working collaboratively with the HIV/AIDS community to greatly help meet the needs of people living with this disease, and we are focused on helping make sure that people coping with HIV and AIDS have access to our medicines.’ Related StoriesNew study finds high prevalence of HIV among pregnant refugee ladies in OntarioStudy: Safe spaces may play critical function in community-based HIV prevention effortsSafe, effective douche-based rectal microbicide can prevent HIV in gay males’AHF has repeatedly pointed out to BMS that the high price of its medication Reyataz is adding to a crisis that has left thousands of patients without access to lifesaving AIDS treatment,’ said Michael Weinstein, President of AIDS Health care Base.Related StoriesChildren's Memorial Hermann Hospital presents Halloween safety tipsLoyola Medicine, Palos Community Hospital jointly start innovative telemedicine programGlan Clwyd Medical center N Wales spend money on Esaote's G-Scan MRI device for weight-bearing scanning Financial Outlook AcelRx information as revenue the reimbursement received pursuant to the 2011 $5.6 million USAMRMC grant.through December 31 6 million, 2013 without funding staying on the USAMRMC grant.0 million milestone payment anticipated in the 3rd quarter of 2014.